iRhythm Technologies, Inc. Stock

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 03:41:46 2024-04-26 pm EDT 5-day change 1st Jan Change
112.1 USD +0.71% Intraday chart for iRhythm Technologies, Inc. -0.38% +4.32%
Sales 2024 * 581M Sales 2025 * 688M Capitalization 3.46B
Net income 2024 * -90M Net income 2025 * -51M EV / Sales 2024 * 5.88 x
Net cash position 2024 * 45.37M Net cash position 2025 * 75.08M EV / Sales 2025 * 4.92 x
P/E ratio 2024 *
-38.2 x
P/E ratio 2025 *
-68.1 x
Employees 2,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.22%
More Fundamentals * Assessed data
Dynamic Chart
IRhythm Technologies Closes $661 Million Notes Offering MT
Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing MT
IRhythm Technologies Prices $575 Million Convertible Notes Offering MT
IRhythm Shares Fall After Firm Plans $450 Million Convertible Notes Offering MT
IRhythm Technologies Plans to Offer $450 in Convertible Notes Due 2029 MT
Needham Adjusts iRhythm Technologies' Price Target to $137 From $136, Keeps Buy Rating MT
IRhythm Technologies Q4 Adjusted Loss Widens, Revenue Rises; 2024 Sales Outlook Set -- Shares Slump After Hours MT
Transcript : IRhythm Technologies, Inc., Q4 2023 Earnings Call, Feb 22, 2024
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
IRhythm Technologies, Inc. Provides Earnings Guidance for the Year 2024 CI
IRhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Transcript : IRhythm Technologies, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM
IRhythm Technologies Closes $150 Million Debt Facility; 2024 Revenue Forecast Issued MT
Needham Raises iRhythm Technologies' Price Target to $136 From $108, Keeps Buy Rating MT
Irhythm Technologies, Inc. Entered into A Credit, Security and Guaranty Agreement with Braidwell Transaction Holdings LLC CI
More news
1 day-4.43%
1 week-0.76%
Current month-4.08%
1 month-1.22%
3 months-5.87%
6 months+47.49%
Current year+3.95%
More quotes
1 week
110.80
Extreme 110.8
118.43
1 month
106.20
Extreme 106.2
118.43
Current year
97.50
Extreme 97.5
124.12
1 year
70.24
Extreme 70.24
135.80
3 years
41.66
Extreme 41.6559
169.54
5 years
41.66
Extreme 41.6559
286.19
10 years
22.16
Extreme 22.16
286.19
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 21-10-03
Director of Finance/CFO - 22-08-07
Chief Tech/Sci/R&D Officer - 22-04-27
Members of the board TitleAgeSince
Chairman 60 16-04-30
Director/Board Member 66 16-02-29
Director/Board Member 84 17-07-18
More insiders
Date Price Change Volume
24-04-26 111.6 +0.33% 248 009
24-04-25 111.3 -4.43% 412,936
24-04-24 116.4 +0.08% 330,725
24-04-23 116.3 +2.39% 203,258
24-04-22 113.6 +1.36% 301,248

Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT

More quotes
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
111.3 USD
Average target price
138.5 USD
Spread / Average Target
+24.47%
Consensus